1. |
Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the framingham heart study. JAMA, 1994, 271(11): 840.
|
2. |
周自强, 胡大一, 陈捷, 等. 中国心房颤动现状的流行病学研究. 中华内科杂志, 2004, 43(7): 491-494.
|
3. |
Wang X, Fu Q, Song F, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: results from a national stroke screening survey. Int J Cardiol, 2018, 271: 92-97.
|
4. |
梅举, 姜兆磊, 汤敏, 等. 微创心脏瓣膜手术同期双房冷冻消融治疗合并心房颤动. 中国胸心血管外科临床杂志, 2017, 24(1): 25-29.
|
5. |
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 1991, 22(8): 983.
|
6. |
Guo Y, Tian Y, Wang H, et al. Prevalencmne, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest, 2015, 147(1): 109-119.
|
7. |
陈新, 张澍, 胡大一, 等. 心房颤动: 目前认识和治疗建议. 中华心律失常学杂志, 2001, 5(2): 69-94.
|
8. |
AGREE Next Steps Consortium. The AGREE Ⅱ instrument, 2009. Available at: http://www.agreetrust.org.
|
9. |
Sabharwal S, Patel V, Nijjer SS, et al. Guidelines in cardiac clinical practice: evaluation of their methodological quality using the AGREE Ⅱ instrument. J R Soc Med, 2013, 106(8): 315-322.
|
10. |
Galvez-Olortegui JK, Ãlvarez-Vargas ML, Galvez-Olortegui TV, et al. Current clinical practice guidelines in atrial fibrillation: a review. Medwave, 2016, 16(1): 6365.
|
11. |
Institute of Medicine (US) Committee to advise the public health service on clinical practice guidelines. Clinical practice guidelines: directions for a new program. Ann Oncol, 1990, 60(9): 343-348.
|
12. |
黄从新, 马长生, 杨延宗, 等. 代表中华医学会心电生理和起搏分会心房颤动治疗专家工作组. 心房颤动: 目前的认识和治疗建议 (二). 中华心律失常学杂志, 2006, 19(3): 167-197.
|
13. |
黄从新, 马长生, 张澍, 等. 经导管消融心房颤动中国专家共识. 中华心律失常学杂志, 2008, 12(4): 248-258.
|
14. |
佚名. 慢性心力衰竭合并心房颤动诊断与治疗中国专家共识. 中国医刊, 2011, 46(1): 78-84.
|
15. |
黄从新, 张澍, 马长生, 等. 心房颤动: 目前的认识和治疗建议-2012. 中国心律失常学杂志, 2012, 16(4): 246-289.
|
16. |
中华医学会心血管病学分会, 心律失常联盟. 心房颤动抗凝治疗中国专家共识. 中华内科杂志, 2012, 51(11): 916-921.
|
17. |
利伐沙班临床应用中国专家组. 利伐沙班临床应用中国专家建议-非瓣膜病心房颤动卒中预防分册. 中华内科杂志, 2013, 52(10): 897-902.
|
18. |
中华医学会心血管病学分会. 非瓣膜病心房颤动患者新型口服抗凝药的应用中国专家共识. 中华心律失常学杂志, 2014, 18(5): 321-329.
|
19. |
黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识和治疗建议-2015. 中国心脏起搏与心电生理杂志, 2015, 19(5): 328-369.
|
20. |
张澍, 杨艳敏, 黄从新, 等. 中国心房颤动患者卒中预防规范. 中华心律失常学杂志, 2015, 19(3): 162-173.
|
21. |
Graham R, Mancher M. Institute of Medicine (US) Committee on standards for developing trustworthy clinical practice guidelines, clinical practice guidelines we can trust. Washington (DC): National Academies Press (US), 2011.
|
22. |
Chen YL, Yao L, Xiao XJ, et al. Quality assessment of clinical guidelines in China: 1993–2010. 中华医学杂志 (英文版), 2012, 125(20): 3660-3664.
|
23. |
韦当, 王小琴, 吴琼芳, 等. 2011 年中国临床实践指南质量评价. 中国循证医学杂志, 2013, 13(6): 760-763.
|
24. |
李楠, 姚亮, 吴琼芳, 等. 2012–2013 年中国大陆期刊发表临床实践指南质量评价. 中国循证医学杂志, 2015, 15(3): 259-263.
|
25. |
Álvarez-Vargas ML, Galvez-Olortegui JK, Galvez-Olortegui TV, et al. Clinical practice guidelines in hypertension: a review. Medwave, 2015, 15(9): e6290.
|
26. |
Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.
|
27. |
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
|
28. |
Avaliable at: http://www.gradeworkinggroup.org.
|
29. |
Gordon G, Andrew DO, Elie A, et al. GRADE 指南: Ⅰ.导论-GRADE 证据概要表和结果总结表. 中国循证医学杂志, 2011, 11(4): 437-445.
|
30. |
Zheng ZH, Cui SQ, Lu XQ, et al. Analysis of the status of Chinese clinical practice guidelines development. Bmc Health Serv Res, 2012, 12(1): 218.
|
31. |
Detsky AS. Sources of bias for authors of clinical practice guidelines. CMAJ, 2006, 175(9): 1033, 1035.
|